Harvest Portfolios Group Inc. Announces Big Pharma Split Corp. Overnight Offering
24 Février 2021 - 9:17PM
Harvest Portfolios Group Inc. (“Harvest”) is pleased to announce
that Big Pharma Split Corp. (the “Company”) will undertake an
offering of Preferred Shares and Class A Shares of the Company. The
offering will be led by BMO Capital Markets and will include CIBC
World Markets Inc., and Scotia Capital Inc.
The Preferred Shares will be offered at a price
of $10.50 per Preferred Share to yield 4.80% and the Class A Shares
will be offered at a price of $13.75 per Class A Share to yield
9.0%.
The closing price on the TSX of each of the
Preferred Shares and the Class A Shares on February 24, 2021 was
$10.52 and $13.99, respectively.
The net proceeds of the offering will be used to
invest in an equally-weighted portfolio of ten issuers comprised of
equity securities selected by Harvest from a universe of
pharmaceutical issuers. In order to seek to generate additional
returns, Harvest may write call options each month in respect to
some or all of the equity securities in the Portfolio.
Eli Lilly and Company Johnson &
Johnson Amgen Inc. Novartis AG
Pfizer Inc.
AstraZeneca PLC Sanofi SA
Merck & Co Inc. Bristol-Myers Squibb
Company AbbVie Inc.
The investment objectives for the Preferred
Shares are to provide their holders with fixed cumulative
preferential quarterly cash distributions in the amount of $0.125
per Preferred Share ($0.50 per annum) until December 31, 2022 (the
“Maturity Date”) and to return of the original issue price to
holders on the Maturity Date.
The investment objectives for the Class A Shares
are to provide their holders with regular monthly cash
distributions targeted to be $0.1031 per Class A Share ($1.2372 per
annum) and with the opportunity for growth in net asset value per
Class A Share.
Harvest is the manager, portfolio manager and
promoter of the Company.
The sales period of this overnight offering will
end at 9:00 a.m. EST on February 25, 2021. The offering is expected
to close on or about March 4, 2021 and is subject to certain
closing conditions including approval by the Toronto Stock
Exchange.
For additional information: Please visit
www.harvestportfolios.com, e-mail info@harvestportfolios.com or
call toll free 1-866-998-8298.
About Harvest Portfolios Group Inc.
Founded in 2009, Harvest is a Canadian
Investment Fund Manager managing over $1.2 billion in assets for
Canadian Investors. Harvest offers an innovative suite of exchange
traded funds, mutual funds and publicly-listed structured fund
products designed to satisfy the long-term growth and income needs
of investors. We pride ourselves in creating trusted investment
solutions that meet the expectations of our investors.
A prospectus supplement to the Company’s short
form base shelf prospectus dated November4, 2020 containing
important detailed information about the Preferred Shares and the
Class A Shares being offered will be filed with the securities
commissions or similar authorities in all provinces of Canada.
Copies of the prospectus supplement and the short form base shelf
prospectus may be obtained from your registered financial advisor
using the contact information for such advisor, or from
representatives of the agents listed above. There will not be any
sale or any acceptance of an offer to buy the securities being
offered until the prospectus supplement has been filed with the
Securities Commissions or similar authorities in each of the
provinces and territories of Canada.
Big Pharma Split (TSX:PRM)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Big Pharma Split (TSX:PRM)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024